Laboratorios Richmond S.A.C.I.F. (RICH.BA)

ARS 1460.0

(1.74%)

Market Cap (In ARS)

116.25 Billion

Revenue (In ARS)

39.02 Billion

Net Income (In ARS)

-10.85 Billion

Avg. Volume

12.87 Thousand

Currency
ARS
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1715.0-1770.0
PE
909.66
EPS
1.605
Beta Value
-0.067
ISIN
ARLRIC300027
CUSIP
-
CIK
-
Shares
79626030.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Juan Manuel Artola
Employee Count
-
Website
https://www.richmondlab.com
Ipo Date
Details
Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is headquartered in Buenos Aires, Argentina.